| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Breno Sanvicente-Vieira, Diego Luiz Rovaris, Felipe Ornell, Anne Sordi, Leonardo Melo Rothmann, João Paulo Ottolia Niederauer, Jaqueline Bohrer Schuch, Lisia von Diemen, Felix Henrique Paim Kessler, Rodrigo Grassi-Oliveir. Sex-based differences in multidimensional clinical assessments of early-abstinence crack cocaine users. PloS one. vol 14. issue 6. 2020-02-11. PMID:31226126. |
a total of 1344 inpatients (798 males and 546 females) with crack cocaine use disorder (cud) were evaluated by a detailed multidimensional clinical assessment, including addiction severity and trauma exposure. |
2020-02-11 |
2023-08-13 |
Not clear |
| Verica Milivojevic, Jonathan Covault, Gustavo A Angarita, Kristen Siedlarz, Rajita Sinh. Neuroactive steroid levels and cocaine use chronicity in men and women with cocaine use disorder receiving progesterone or placebo. The American journal on addictions. vol 28. issue 1. 2020-01-31. PMID:30537098. |
here, we evaluated a panel of nas in men and women with cocaine use disorder (cud) who participated in a clinical laboratory study of progesterone. |
2020-01-31 |
2023-08-13 |
Not clear |
| Derek Blevins, Xin-Qun Wang, Sana Sharma, Nassima Ait-Daou. Impulsiveness as a predictor of topiramate response for cocaine use disorder. The American journal on addictions. vol 28. issue 2. 2020-01-31. PMID:30664303. |
we sought to determine whether impulsiveness could predict topiramate treatment response in individuals with cocaine use disorder (cud). |
2020-01-31 |
2023-08-13 |
Not clear |
| Gene-Jack Wang, Corinde E Wiers, Elena Shumay, Dardo Tomasi, Kai Yuan, Christopher T Wong, Jean Logan, Joanna S Fowler, Nora D Volko. Expectation effects on brain dopamine responses to methylphenidate in cocaine use disorder. Translational psychiatry. vol 9. issue 1. 2020-01-15. PMID:30770780. |
here we assessed the effect of expectation on methylphenidate (mp)-induced striatal da changes in 23 participants with an active cocaine use disorder (cud) and 23 healthy controls (hc) using [ |
2020-01-15 |
2023-08-13 |
human |
| Caroline Camilo, Mariana Maschietto, Henrique C Vieira, Ana C Tahira, Gisele R Gouveia, Ana C Feio Dos Santos, André B Negrão, Marcelo Ribeiro, Ronaldo Laranjeira, Homero Vallada, Helena Brentan. Genome-wide DNA methylation profile in the peripheral blood of cocaine and crack dependents. Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999). vol 41. issue 6. 2020-01-10. PMID:31116258. |
to better understand the interaction between the environmental modulations and phenotype, the aim of the present study was to investigate the dna methylation pattern of cud patients, who had concomitant cocaine and crack dependence, and healthy controls. |
2020-01-10 |
2023-08-13 |
Not clear |
| Christina Gobin, John Shallcross, Marek Schwend. Neurobiological substrates of persistent working memory deficits and cocaine-seeking in the prelimbic cortex of rats with a history of extended access to cocaine self-administration. Neurobiology of learning and memory. vol 161. 2019-12-24. PMID:30946882. |
cocaine use disorder (cud) is associated with prefrontal cortex dysfunction and cognitive deficits that may contribute to persistent relapse susceptibility. |
2019-12-24 |
2023-08-13 |
rat |
| Nuria García-Marchena, Marta Barrera, Joan Ignasi Mestre-Pintó, Pedro Araos, Antonia Serrano, Clara Pérez-Mañá, Esther Papaseit, Francina Fonseca, Juan Jesús Ruiz, Fernando Rodríguez de Fonseca, Magí Farré, Francisco Javier Pavón, Marta Torren. Inflammatory mediators and dual depression: Potential biomarkers in plasma of primary and substance-induced major depression in cocaine and alcohol use disorders. PloS one. vol 14. issue 3. 2019-12-12. PMID:30870525. |
patients diagnosed with cocaine (cud, n = 64) or alcohol (aud, n = 65) use disorders with/without mdd were recruited from outpatient treatment programs [cud/non-mdd (n = 31); cud/primary mdd (n = 18); cud/cocaine-induced mdd (n = 15); aud/non-mdd (n = 27); aud/primary mdd (n = 16) and aud/alcohol-induced mdd (n = 22)]. |
2019-12-12 |
2023-08-13 |
human |
| André Q C Miguel, Brian D Kiluk, Theresa A Babuscio, Charla Nich, Jair J Mari, Kathleen M Carrol. Short and long-term improvements in psychiatric symptomatology to validate clinically meaningful treatment outcomes for cocaine use disorders. Drug and alcohol dependence. vol 198. 2019-11-25. PMID:30921648. |
psychiatric symptomatology is prevalent among those seeking treatment for cocaine use disorder (cud). |
2019-11-25 |
2023-08-13 |
Not clear |
| Muhammad A Parvaz, Scott J Moeller, Pias Malaker, Rajita Sinha, Nelly Alia-Klein, Rita Z Goldstei. Abstinence reverses EEG-indexed attention bias between drug-related and pleasant stimuli in cocaine-addicted individuals. Journal of psychiatry & neuroscience : JPN. vol 41. issue 5. 2019-11-20. PMID:27434467. |
in this study we used the late positive potential (lpp) to investigate whether such increased attention bias toward drug-related relative to non-drug-related cues changes over a protracted period of reduced drug use in treatment-seeking individuals with a cocaine use disorder (cud). |
2019-11-20 |
2023-08-13 |
Not clear |
| Brian D Kangas, Rachel J Doyle, Stephen J Kohut, Jack Bergman, Marc J Kaufma. Effects of chronic cocaine self-administration and N-acetylcysteine on learning, cognitive flexibility, and reinstatement in nonhuman primates. Psychopharmacology. vol 236. issue 7. 2019-11-04. PMID:30877326. |
cocaine use disorder (cud) is associated with cognitive deficits that have been linked to poor treatment outcomes. |
2019-11-04 |
2023-08-13 |
Not clear |
| Barak W Gunter, Robert W Gould, Michael Bubser, Kevin M McGowan, Craig W Lindsley, Carrie K Jone. Selective inhibition of M Addiction biology. vol 23. issue 5. 2019-10-22. PMID:29044937. |
selective inhibition of m cocaine use disorder (cud) remains a debilitating health problem in the united states for which there are no food and drug administration-approved treatment options. |
2019-10-22 |
2023-08-13 |
Not clear |
| James J Mahone. Cognitive dysfunction in individuals with cocaine use disorder: Potential moderating factors and pharmacological treatments. Experimental and clinical psychopharmacology. vol 27. issue 3. 2019-07-22. PMID:30556731. |
it is well-documented in the literature that individuals repeatedly exposed to cocaine exhibit cognitive impairment and that cognitive dysfunction is a risk factor for poor treatment outcomes in those with cocaine use disorder (cud). |
2019-07-22 |
2023-08-13 |
Not clear |
| Danielle Ruiz Lima, Priscila Dib Gonçalves, Mariella Ometto, Andre Malbergier, Ricardo Abrantes Amaral, Bernardo Dos Santos, Mikael Cavallet, Tiffany Chaim-Avancini, Mauricio Henriques Serpa, Luiz Roberto Kobuti Ferreira, Fabio Luis de Souza Duran, Marcus Vinicius Zanetti, Sergio Nicastri, Geraldo Filho Busatto, Arthur Guerra Andrade, Paulo Jannuzzi Cunh. The role of neurocognitive functioning, substance use variables and the DSM-5 severity scale in cocaine relapse: A prospective study. Drug and alcohol dependence. vol 197. 2019-06-25. PMID:30875646. |
this study aimed to investigate the relationship between dsm-5 criteria, neurocognitive functioning, substance use variables and cocaine relapse among inpatients with cocaine use disorder (cud). |
2019-06-25 |
2023-08-13 |
Not clear |
| Marguerite M Patel, David A Nielsen, Thomas R Kosten, Richard De La Garza, Thomas F Newton, Christopher D Verric. FAAH variant Pro129Thr modulates subjective effects produced by cocaine administration. The American journal on addictions. vol 27. issue 7. 2019-06-10. PMID:30126012. |
we hypothesized that cocaine use disordered (cud) participants with the faah pro129 thr variant would exhibit a distinct profile of cocaine-induced subjective effects in the laboratory. |
2019-06-10 |
2023-08-13 |
human |
| Joy M Schmitz, Angela L Stotts, Anka A Vujanovic, Michael F Weaver, Jin H Yoon, Jessica Vincent, Charles E Gree. A sequential multiple assignment randomized trial for cocaine cessation and relapse prevention: Tailoring treatment to the individual. Contemporary clinical trials. vol 65. 2019-05-28. PMID:29287664. |
for cocaine use disorders (cud), specifically, the most potent intervention currently available for initiating abstinence is behavior therapy using contingency management (cm) procedures, with early cessation being a robust predictor of future abstinence. |
2019-05-28 |
2023-08-13 |
Not clear |
| Gabriel Rodrigo Fries, Sarwar Khan, Sydney Stamatovich, Elena Dyukova, Consuelo Walss-Bass, Scott D Lane, Joy M Schmitz, Margaret C Wardl. Anhedonia in cocaine use disorder is associated with inflammatory gene expression. PloS one. vol 13. issue 11. 2019-04-22. PMID:30408130. |
treatments for cocaine use disorder (cud) are variably effective, and there are no fda-approved medications. |
2019-04-22 |
2023-08-13 |
human |
| Maenia Scarpino, Giovanni Lanzo, Maya Salimova, Francesco Lolli, Amedeo Del Vecchio, Cesarina Cossu, Maria Bastianelli, Brunella Occupati, Cecilia Lanzi, Stefano Pallanti, Aldo Amantini, Guido Mannaioni, Antonello Gripp. Efficacy of high-frequency (15Hz) repetitive transcranial magnetic stimulation (rTMS) of the left premotor cortex/dorsolateral prefrontal cortex in decreasing cocaine intake (the MagneTox study): A study protocol for a randomized placebo-controlled pilot trial. Neurophysiologie clinique = Clinical neurophysiology. vol 49. issue 1. 2019-04-04. PMID:30712533. |
cocaine use disorder (cud) is very common and has psychological and physical consequences. |
2019-04-04 |
2023-08-13 |
Not clear |
| Marek Schwendt, John Shallcross, Natalie A Hadad, Mark D Namba, Helmut Hiller, Lizhen Wu, Eric G Krause, Lori A Knacksted. A novel rat model of comorbid PTSD and addiction reveals intersections between stress susceptibility and enhanced cocaine seeking with a role for mGlu5 receptors. Translational psychiatry. vol 8. issue 1. 2019-04-01. PMID:30291225. |
ptsd is highly comorbid with cocaine use disorder (cud), and cocaine users with ptsd + cud are more resistant to treatment. |
2019-04-01 |
2023-08-13 |
rat |
| Matthias Kirschner, Ronald Sladky, Amelie Haugg, Philipp Stämpfli, Elisabeth Jehli, Martina Hodel, Etna Engeli, Sarah Hösli, Markus R Baumgartner, James Sulzer, Quentin J M Huys, Erich Seifritz, Boris B Quednow, Frank Scharnowski, Marcus Herdene. Self-regulation of the dopaminergic reward circuit in cocaine users with mental imagery and neurofeedback. EBioMedicine. vol 37. 2019-03-12. PMID:30377073. |
enhanced drug-related reward sensitivity accompanied by impaired sensitivity to non-drug related rewards in the mesolimbic dopamine system are thought to underlie the broad motivational deficits and dysfunctional decision-making frequently observed in cocaine use disorder (cud). |
2019-03-12 |
2023-08-13 |
Not clear |
| John Marsden, Camille Goetz, Tim Meynen, Luke Mitcheson, Garry Stillwell, Brian Eastwood, John Strang, Nick Gre. Memory-Focused Cognitive Therapy for Cocaine Use Disorder: Theory, Procedures and Preliminary Evidence From an External Pilot Randomised Controlled Trial. EBioMedicine. vol 29. 2018-09-05. PMID:29478874. |
cocaine use disorder (cud) is a debilitating condition with no nice-recommended medication or specific psychosocial interventions. |
2018-09-05 |
2023-08-13 |
Not clear |